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ABSTRACT
The full potential of state-of-the-art space
radiation dose analysis for manned missions has
not been exploited. Point doses have been over-
emphasized, and the critical dose to the bone
marrow has been only crudely approximated,
despite the existence of detailed man models and
computer codes for dose integration in complex
geometries. The method presented makes it
practical to account for the geometrical detail of
the astronaut (which typically provides as much
protection to the internal organs as does the
vehicle) as well as the vehicle. This paper dis-
cusses the major assumptions involved and pre-
sents the concept of applying the results of
detailed proton dose analysis to the real-time
interpretation of on-board dosimetric
measurements.
INTRODUCTION
Present state-of-the-art methods for space
radiation dose analysis have been routinely used
on a number of existing and proposed manned
space systems. The experience gained in.apply-
ing the involved analytical techniques, the extent
of agreement between analytical results and
experimental investigations, and the increased
knowledge of the space radiation environment
have resulted in reasonable confidence in the
ability to predict space radiation doses to specific
points in a vehicle used for manned missions. A
summary of the state-of-the-art and current
practices is given in reference I; the current
experimental approach and experimental results
are summarized in reference 2.
The most troublesome and important space-
radiation protection problem continues to be that
of biological hazard, and one of the most difficult
aspects of the biological hazard problem is
onboard dose monitoring. The most stringent bio-
logical dose criterion is generally that associated
with the internally distributed blood-forming
organs (BFO) or bone marrow, and the critical
radiation environment for practically all manned
missions is protons, both solar protons and
trapped protons. It is in the context of these
generalizations that this paper is presented.
SCOPE OF PRESENT DISCUSSION
Considerable theoretical and experimental
effort has gone into establishing and improving
the accuracy of present methods for calculating
point doses, and there seems little to be gained
in further efforts along these lines at this point.
Emphasis should instead be placed on improving
the application of these methods to preflight and
in-flight dose estimation. The two major points
of this paper concern (1) astronaut self-shielding
of internally distributed organs, and (Z) the
realistic interpretation of on-board dosimetry.
The aspect of dose analysis that in particu-
lar deserves more attention is the effective
utilization of detailed astronaut (as well as
vehicle) geometry. Available methods for esti-
mating point doses are rather accurate for
geometrically well-defined systems, particularly
for protons. However, the application of these
methods to the estimation of doses to the
internally distributed organs (such as the BFO)
of a mobile astronaut has not exploited the avail-
able potential for obtaining accurate dose esti-
mates. This is because the complexity involved
in the combined geometrical mockup of a vehicle
and a mobile detailed man-model requires exces-
sive time and effort to integrate over the several
space and time variables involved in the dose
integrations. The geometrical complexity
involved can be appreciated by viewing a model
or mockup of the NASA Space Station and con-
sidering a man-model described by over 2200
geometrical shapes (ref. 3). The alternative to
precise "brute-force" integration that has seen
widespread application is the use of gross simpli-
fications, such as characterizing the average BFO
dose by a few point doses calculated at a 5-cm
depth in a phantom. Because the protection pro-
vided to the BFO by the vehicle may well -be less
than that provided by the self-shielding of the
astronaut and because the protection provided by
both is highly spectrum dependent, this degree of
simplification largely negates the care normally
taken with other aspects of dose analysis; for
example, in specifying the quality factor and the
vehicle mass distribution. The approach pre-
sented utilizes the available capability of detailed
man-n_odels and circumvents the problems of
excessive effort on the one hand and excessive
crudeness on the other.
Another area requiring attention is the
application of the significant dose analysis capa-
bility that has been developed over the past ten
years to the problem of on-board dose monitoring.
The uncertainty associated with preflight dose
estimation, in decreasing order of importance,
is due to (1) the space environment encountered
during the mission, (2) the distribution of mass
providing protection, and (3) methods of radiation
transport and dose analysis (ref. 4). In situ
measurements, however, remove the major
source of uncertainty (that associated with the
radiation environment) so that the main dose
uncertainties are then due to the combined mass
distribution of the vehicle and astronaut. An
accurate treatment of the overall geometrical
arrangements ot mass will therefore enhance the
overall accuracy of dose estimation. It is pre-
cisely this sensitivity of dose to mass distribution
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for mannedspacesystemsthatmakesdirect
dos[metricmeasurementsimpracticalin real-
timedosemonitoring. Anapproachis presented
for makingpracticaluseof availabledoseanaly-
sis toolsanddetailedman-modelsto providea
meansof realistic, real-timeinterpretationof
on-boarddosimetricmeasurements.
REPRESENTATION OF ASTRONAUT
GEOMETRY AND MOTION
The usual method of estimating dose to the
BFO (for example) of a mobile astronaut has been
to create a geometrical mockup of a man-model
inside the space system, and to perform dose
integrations about several points in the body,
each of which is erroneously assumed to be at a
uniform depth of 5 g/cm 2, for several man-model
locations within the vehicle. This procedure
represents a compromise in the spatial and
astronaut time-line integrations, and makes it
impractical to use both a detailed mockup of the
vehicle and a detailed man-model of the type
described in reference 3.
The alternative method that has been developed
yields improved dose estimates by accounting for
the actual organ distribution within the body, the
dose distribution within the organ, and the astro-
naut time-line. Such a detailed integration is
made practical by decoupling the mass distribu-
tion of the vehicle from the mass distribution of
the astronaut. This is accomplished by using
mass-distribution data generated from an existing
detailed man-model to express the shielding
effect of the body on critical organ dose. Typical
mass distributions for the BFO are shown as
curves 2 and 3 in figure 1. When fully imple-
mented, each curve generated would be volume-
averaged over some portion of theBFO; that is,
each curve would represent a part of the BFO
(e. g., upper limbs, lower limbs, ribs and trunk,
spinal column, and skull) rather than a point, as
in figure 1. Other distributed radiatlon-sensitive
organs (e. g., the gut) could be treated similarly,
and if it turns out to be important, these data
should be generated for both the standing and the
sitting positions. Doses to the skin and lens of
the eye are essentially surface doses for which
body self-shielding can be adequately estimated
without the explicit use of a man-model (ref. 5).
The mass distribution data of figure 1 were
generated by tracing several hundred randomly
selected rays. Curve 1 is the time-averaged
distribution for a simplified astronaut time-line
made up of five dwell stations in the Skylab
vehicle that account for most of the time, with
the remainder of the time spent in uniform transit
between the station locations. A more detailed
time-line could be constructed from measured
data like those presented in reference 6. Curve 1
was generated with the use of the SIGMA code
(ref. 7). Curves 2 and 3 were generated for an
isolated, standing astronaut with the MEVDP code
(ref. 8), which contains the man-model of
/'eference 3.
Such astronaut mass distribution data have
been combined with the vehicle mass-distrlbution
data in two ways. One way of combining them in
a dose analysis has been to use them in the same
manner that a man-model is now used; i. e.,
using the organ mass distribution to calculate
depth doses for each ray as it is traced, and then
summing the desired results. Another way,
which is more efficient when integration over
astronaut time-line is involved, has been to gen-
erate the time-line averaged vehicle mass distri-
bution separately (such as indicated by curve 1,
figure 1), and then obtain the final results by
convoluting the mass distributions and integrating
over the dose kernels and organ response (i. e.,
the distribution factor or other dose-modifying
factors). This latter approach is illustrated in
figure Z, in which the utilization of man-model
geometrical mockup is shown in dashed lines to
indicate that it is used only once and not in every
dose analysis.
The advantages of the decoupling method over
the present method are:
1. Dose estimates to such organs as the
BFO are significantly more accurate and realistic.
2. Application of the available detailed man-
model capability is made practical.
3. Much greater detail in dose analysis for
either the final design or preliminary analysis i's
obtainable with a small increase in engineering
effort and with reduced computer time.
4. Ability to interpret data from on-board
monitoring is enhanced.
The implementation of the proposed method
involves the following assumptions: (1) the
effects of an astronaut's actual orientation on
dose are not significant on the average, (X) the
error involved in using a single reference
material in the dose kernels is not significant,
and (3) the vehicle mass distribution at a point
is representative of a region of space (occupied
by one or more organ segments, as necessary).
A series of calculations indicates the validity of
the first two assumptions. The third assumption
is not considered restrictive, since vehicle mass
distributions can be generated on the basis of a
single coordinate time-line for an astronaut or
as many as one coordinate time-line for each
organ mass-distribution curve of interest,
depending on how a specific situation affects the
accuracy•
EVALUATION OF DOSE INTEGRATION
TECHNIQUES
A 44-region geometrical mockup of a
manned space station (ref. 9) and a simple
man-model consisting of one elliptical cylinder
for the head and another for the trunk were used
to perform a series of calculations with the
SIGMA code. Doses were calculated for a point
representing the lens of the eye at a single man-
model location. A surface dose was chosen to
emphasize any effects of man-model orientation
with respect to the vehicle• Two proton spectra
were used: an exponential rigidity spectrum
(P = 91 MV) for solar cosmic rays and an
O •
exponential energy spectrum (E = 94 MEV) for
• O .
trapped protons. The calculations illustrate
several possible approaches to dose analysis,
indicate the effects of vehicle/man-model
orientation, and provide a comparison between
random and systematic ray-tracing. The results
are summarized in table 1.
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The conventional method of dose analysis
corresponds to case 1, for which a combined
geometrical mockup is used for both the vehicle
and the astronaut, thereby maintaining a fixed
specific vehicle/man-model orientation. The
method of dose integration uses a systematic
sectoring and ray-tracing procedure. Case 2
provides a comparison with case 1 with respect
to random versus systematic ray-tracing. This
is of interest because the more variables or
dimensions involved in an integration, the more
advantageous the Monte Carlo technique will be
from a computational standpoint. Therefore,
the generation of astronaut mass distributions
and the dose integration for a detailed time-line
using random ray-tracing (i.e., Monte Carlo
integration) would significantly reduce the compu-
tation cost relative to that required for system-
atic ray-tracing (i.e., direct numerical
integration) for the same precision. Table 1
shows that, even for a simple example with
integrations employing 500 rays, Monte Carlo
integration is superior; a more complex integra-
tion would show a greater advantage. Case 2
was also run, using 5,000 rays to obtain an
accurate result as a basis for comparison. In
this case, the solar cosmic-ray dose calculated
by the Monte Carlo technique (using 500 rays)
was more accurate than that obtained with
systematic ray-tracing.
For dose integrations of reasonable accuracy,
at least 100 rays are required (as shown later).
For this many rays, there is no mathematical or
practical justification for elaborately sectoring and
tracing rays through sector centroids; this approach
is attractive only because it corresponds to a
mental construct. For systematic ray-tracing,
parts of the solid angle space will always be
inaccessible to rays; this is not true of random
sampling. If there are thin regions or "windows,"
the bias used in sectoring can easily be applied
to Monte Carlo integration, although this is
unnecessary for all sizable space vehicles
examined to date (including several configura-
tions of MORL, MOL, Skylab, and the Space
Station).
Cases 3 and 4 are similar to cases 1 and 2,
except they demonstrate the use of a man-model
mass distribution (defined by a histogram)
applied as indicated in figure 2. The doses are
slightly higher for cases 3 and 4 because of the
lack of a fixed vehicle/man-model orientation.
The higher doses thus obtained are to be
expected because the minimum in the astronaut
mass distribution is exposed to the direction of
maximum flux (as well as all other directions).
It is also true that the larger conservative dose
is the desirable one to use except in a special
(and unlikely) situation in which an astronaut's
orientation is severely and reliably restricted
for a significant period of time.
Case 5 indicates how little computation is
involved in dose integration aside fronl ray-
tracing computations. Once mass distributions
are available, it is a trivial matter for a large
computer to perform the dose integrations, and
the amount of time involved is independent of
geometrical complexity. The vehicle histogram
used in case 5 was generated from the ray-
tracing analyses performed for case 4. There-
fore, the dose results from case 5 should, and
do, agree with the case 4 results, in which some
portions of the mass distribution data were
obtained by ray-tracing instead of sampling a
histogram.
Summarizing, the conclusions supported by
table I are as follows:
1. The doses for oriented cases closely
agree with those for unoriented cases, the
unoriented cases giving slightly higher doses
because the use of a separate man-model mass
distribution exposes the minimum mass thickness
to the direction of maximum flux; use of a
surface dose in the examples emphasizes this
effect. Because of the unlikelihood of being able
to confidently predict a nonuniform astronaut
orientation in most phases of the astronaut time-
line, and because an unoriented man mod_l will
usually yield a slightly conservative dose, this
as sumption is gene rally de sirable.
Z. The use of random ray-tracing for
performing dose integration or generating mass
distributions is virtually always advantageous,
relative to direct numerical integration, even for
a one- or two-variabie integration, such as the
ones performed here, where the two variables
are spherical angular coordinates. When the
vehicle mass distribution is calculated for a
detailed astronaut time-line, the use of random
sampling in time and solid angle to establish
the origin and direction of rays is much more
efficient than the conventional systematic-
sectoring procedure.
CONVERGENCE OF DOSE INTEGRATION
A general aspect of dose calculations that
relates to the above discussion is the convergence
of the dose estimate with the number of rays
traced and the associated uncertainty in the dose
estimate. The standard deviations in table 1
indicate consistent convergence, and assuming
that the number of rays traced is large enough
for the central-limit theorem to apply, confidence
limits and corresponding dose intervals can be
readily determined by using a normal distribution
with the calculated variance.
The rate of dose convergence decreases as
the steepness of the dose attenuation kernel
increases, so that a soft solar cosmic-ray
spectrum converges slower than a relatively
hard trapped-proton spectrum. The McDonnell
Douglas DACP code was used to in_/estigate the
statistics of a dose estimate using the idealized
but realistic mass distribution of figure 3 and the
12 November 1960 solar-flare event (ref. 10).
DACP performs repetitive convolutions of
probability density functions by numerical
integration to obtain exact statistical results, as
described in reference 11.
The dose probability distributions obtained
for three sample sizes (i.e., number of rays
traced) are shown in figure 4. These curves
represent the frequency of results that can be
obtained with all possible combinations of rays,
for this particular case. For 128 rays, a very
good approximation to a normal distribution is
obtained (i.e., the central-limit theorem applies).
Ii0
Figure 5 shows the convergence in terms of
confidence levels as a function of the number of
rays in a sample. For example, for a 90-percent
confidence level, the actual dose has a 90-percent
probability of falling somewhere between the
5-percent confidence limit curve and the
95-percent confidence limit curve. These curves
can be calculated by assuming a normal distri-
bution for sample sizes greater than approxi-
mately 100 rays.
It is concluded that Monte Carlo dose
integration converges as the calculated variance
implies for reasonable sample sizes (greater
than approximately a hundred rays). For typical
mass distributions, this is true for both random
and systematic ray tracing. For this example,
figure 5 shows that 1, 500 rays are required to
obtain a dose that is 99-percent probable of
being within ±1 percent of the actual
(theoretical) dose. It is emphasized that for
Monte Carlo integration, the statistics are
essentially the same for a single point dose or
for a dose calculated for a detailed astronaut
time-line. This is because for typical vehicles
the average mass distribution does not vary so
drastically from point to point that the rate
of convergence is ,significantly affected by
including the effect of a time-line. This is in
marked contrast to conventional dose analysis,
which requires convergence for each of a number
of point doses, which are then appropriately
summed.
VALIDITY OF EQUIVALENT
ALUMINUM CONCEPT
In implementing the foregoing dose evaluation
technique, it is extremely advantageous to repre-
sent proton dose attenuation kernels in terms of
a reference material like aluminum. While the
use of equivalent aluminum seems generally to
be accepted for preliminary analysis, the ques-
tioh often arises about its validity for detailed
analysis, particularly with regard to secondary
nucleon dose.
Briefly, the equivalent aluminum concept
refers to the practice of performing charged-
particle dose-transmission calculations through
a single reference material, usually taken to be
aluminum, and using these results to describe
the dose transmission through any laminated
arrangement of different materials. Its applica-
tion simply involves modifying the actual mass
density of a shield material by its relative stop-
ping power, which is the (practically energy-
independent} ratio of the stopping power of the
material to that of aluminum. This relationship
must be used to give accurate results for primary
proton dose; expressing fhe material in actual
areal density is not adequate.
The question of validity must be answered
in terms of the environment, maferials, and
calculational methods relevant to the subject.
Four cases, which were chosen for analysis,
represent fairly extreme but reasonable arrange-
ments of dissimilar materials that might be
encountered in a manned space system. These
cases were analyzed with the CHARGE code
(ref. 12), which compares well with ORNL NTC
code results (ref. 13). For these cases, a
typical solar proton spectrum (exponential
rigidity spectrum with Po = 91 MV) was used, and
the results were compared to those for an alum-
inum shield. This energy spectrum is soft enough
for secondary nucleon dose to be dominant at
shield thicknesses approaching 50 g/cm 2, thus
posing a rather severe test.
The results are shown in figure 6, which also
describes the shield configurations. The aluminum
represents vehicle structure, the water repre-
sents tissue, the polyethylene represents stored
food and waste, and the iron represents equip-
ment. The curves, which show only a ?.6-percent
difference at 50 g/cm 2 are surprisingly sim-
ilar considering that the dose at 50 g/cm a is
approximately 90 percent due to secondary
neutrons. Similar curves for solar cosmic-ray
primary proton dose and for total dose from a
typical trapped proton spectrum (not shown) are
represented within a few percent by a single
curve, equivalent aluminum shield thicknesses up
to greater than 50 g/cm 2. Little difference for
the primary proton dose would be expected because
the functional dependence of stopping power with
particle energy is nearly the same for all mate-
rials. A large difference in total dose, however,
and particularly for dose equivalent, might be
expected when secondary neutron dose dominates,
as it does for typical solar cosmic-ray spectra
and large shield thicknesses, because neutron
production and attenuation are material dependent.
Fortunately, as indicated by figure 6, this is not
the case.
One reason for this fortunate coincidence is
that the density correction factor for proton stop-
ping power is also approximately correct for
neutron attenuation. Figure 7 shows the relative
stopping power of some materials. Also shown is
the approximate relationship for the macroscopic
neutron removal cross section, which varies
inversely as the cube root of the atomic number
(except for hydrogen}. Because these relation-
ships are similar, the same material density
correction factor is applicable to both phenomena
for the range of material thicknesses of interest.
Another reason is that secondary neutron
production in common materials is not strongly
material dependent. It varies a factor of two
between aluminum and lead, and differs by only
25 percent between aluminum and iron, as indi-
cated in figure 8. For the cases shown in fig-
ure 6, about two-thirds of all neutron secondaries
were formed in the first 2 g/cm 2 of aluminum
The small differences among the cases at 50 g/cm 2
are due primarily to the differences in neutron
production among the materials beyond Z g/cm 2.
The conclusion drawn from these calculations
is that the use of equivalent aluminum based on
relative stopping power in proton dose calcula-
tions is sufficiently accurate for the detailed
design of manned spacecraft. This is because the
relatively small error in the dose kernel at large
shield thicknesses is unimportant to the total dose
because most of the dose involves transmission
through only a few _/cm 2. In addition, the
spread in the curves in figure 6 is only 2.6 per-
cent at 50 g/cm 2, well within the uncertainty
of any calculational technique when secondary
nucleon dose is dominant.
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It shouldbenotedthatthenegligibleerror
indicatedbythiscomparisonis in terms of total
dose,thequantityof interest. Thecomparison
givenin reference14is presentedasa function
of protonenergy,whichresolves{calculated)
variationsthatareinsignificantin their contribu-tion to total dose.
ROLE OF DETAILED DOSE ANALYSIS
IN REAL-TIME DOSE MONITORING
Detailed dose analyses have a proper role
in real-time interpretation of on-board dose-
monitoring information, as welt as in the more
commonly applied area of preflight dose predic-
tion. Direct on-board measurement of the
dosimentric quantities of interest (i.e., critical
organ dose) is not feasible, and dose analyses
must be performed to accurately relate the data
that can be measured to the dosimetric quantities
on which mission decisions are based. The tech-
niques discussed previously, particularly the
technique for making effective use of detailed
man-model geometric data, can be applied to gen-
erate the required relationship between, for
example, spectrometer measurements and
expected organ response.
Solar cosmic rays provide the primary
impetus for establishing a dose-monitoring system
that can assess the dose and dose rate that have
been received and that can project the dose and
dose rate to be expected (ref. 15). There is a
distinct possibili W of exceeding emergency doses
when one considers solar cosmic-ray environ-
ments for orbital missions with inclinations
greater than 40 degrees (ref. 16), or for inter-
planetary missions. Because operational deci-
sions based on dose-monitoring information can
result in severe restrictions or even in mission
abort, it is necessary to be as definite as possible
about interpreting dosimetric data in terms of
actual organ dose and anticipated organ response.
For practical reasons, the significant geometri-
cal factors cannot be accounted for by direct
measurement, but can be determined only by using
the results of detailed calculations to properly
interpret the measurements that can be made.
Regardless of how carefully dose, LET, or any
other similar quantity is measured at a point
or at several points, either on a phantom fixed
in the vehicle or on the astronaut, these data
alone give only a vague indication of actual BFO
dose from solar cosmic rays. The dose behind
5 g/cm 2, regardless of whether it is measured
by a tissue-equivalent dosimeter with good scat -
tering geometry or whether it incorporates other
refinements, does not adequately represent actual
BFOdose from solar cosmic rays (although it is
not unreasonable for neutrons and gamma rays).
Because of the complexity of the geometrical fac-
tors involved, a precise correlation of such
measurements with actual dose or human response
can be established only by detailed dose analysis.
(A discussion of some of the problems and
requirements of dosimetry for manned vehicles
is given in reference 17; a more general survey
is given in reference 18. )
For dose calculations to be made, the radia-
tion environment at some point in the vehicle must
be known. That is, the flux intensity and energy
spectrum must be known; it has not been estab-
lished that incident flux anisotropy is important,
and an attempt to account for it in any detail
would complicate things considerably. Incident
flux, differential in energy, can be measured
directly by a proton spectrometer or it can be
inferred from depth-dose measurements in a
phantom. In either case, the flux at a location
can easily be described as a piece-wise repre-
sentation so that doses anywhere in the vehicle
or astronaunt can then be easily correlated in
real time by using the parametric results of
detailed calculations. Instrument design, opti-
mum dosimetry location, and interpretation of
redundant information are important considera-
tions in the design of a dose-monitoring system,
but they are not the subject of this discussion.
The point of this discussion is to introduce the
idea that combining the versatility of proton-dose
analysis with the reality of direct measurements
can alleviate some of the difficulties of
dosimetry.
GENERAL TECHNIQUE FOR INTERPRETATION
OF DOSE MONITORING DATA
The on-board measurements of proton spectra
will provide data on the flux in several energy
bands or channels at a location in the vehicle, as
indicated by the histogram in figure 9. These
in situ radiation-environment data can then be
converted to astronaut organ dose or dose equiv-
alent through use of a dose transfer function
(DTF) that is generated by using detailed dose
analysis techniques, but is expressed only in
terms of the measured data, i.e., flux magnitude
and energy spectrum. To minimize the error in
the dose estimation, the DTF must represent
these data as a continuous function. The discon-
tinuous data can be converted to a continuous
function (as indicated in figure 9) by assuming a
functional representation within each channel.
The form is relatively unimportant and can be a
power law in energy, an exponential in rigidity,
or some other form for the proton environment.
It can be shown that the measured data can be
quickly converted to a continuous spectrum.
For an isotropic incident flux, which is
piece-wise fitted, with a spectral parameter for
each channel, a total dose response can easily be
obtained by applying the DTF. The DTF consists,
for this example, of I+Z curves (if extrapolations
outside the two spectrometer energy limits are
used) where I is the number of spectrometer
channels. The curves are the normalized dose
per channel as a function of the spectral param-
eter, as shown in figure 10. If there are J dose
responses (e.g., BFOdose, eye dose, etc.),
the DTF for this example would be J(I+2) curves
similar to the curves shown in figure 10. For the
jth dose response, the dose would be given by
I+ 1
Dj = y_ q_i Dij (ai)
i--0
where qJ. is the flux in channel i, where Dij is the
DTF cu#ve for channel i and dose response j, and
where oq is the spectral parameter of channel i.
This same idea can as easily be applied to depth-
dose measurements, rather than spectrometer
measurements, since a given depth-dose curve
represents a unique proton spectrum.
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With this approach, the DTF can include any
level of detail in its generation, without compli-
cating its expression or use. The use of a con-
tinuous piece-wise spectrum defined by a spectral
parameter simplifies the dose conversion and
reduces the error that can be introduced by using
a flux-to-dose conversion, which is a continuous
function of energy.
The accuracy of the doses thus predicted
could be improved by normalizing them to a small,
battery-operated, active, personal dosimeter.
That is, the BFOdose would be scaled to get
the value
where D B is the BFO dose estimate, D_ is the
BFO dose calculated from measured data, D_1is the
the surface dose measured by the personal dosi-
and DC_ is the surface dose calculatedmeter,
from measured data. The value D B could, of
course, represent either accumulated dose or
and D C could be usedinstantaneous dose rate,
for both an average time-line and for specific
fixed locations. Since all the detailed dose
analyses required to construct the DTF would be
precalculated, the simple operations involved in
the application of the DTF could be performed by
a small on-board computer. If necessary, it is
probably practical to perform the conversion by
hand, using nomograms.
CONCLUSIONS AND RECOMMENDATIONS
The following conclusions have been made:
1. Accurate dose estimates require
accounting for:
a. Organ distribution within the body.
b. Dose distribution within an organ.
c. Astronaut time-line.
2. A practical method of implementing
detailed dose analyses is to decouple
vehicle and astronaut mass distributions.
3. Monte Carlo ray-tracing is generally
superior to systematic sectoring.
4. The equivalent aluminum concept is
adequate for proton dose kernels.
5. A DTF using spectral parameters can
provide rapid, real-time, in situ dose
conversion.
The following are recommended:
1. Mass distribution should be generated
for radiation-sensitive organs.
2. The role of dose analysis as it relates to
dose monitoring should be extended to
include the described DTF technique on
future manned space missions.
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